DK173859B1 - Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner - Google Patents
Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner Download PDFInfo
- Publication number
- DK173859B1 DK173859B1 DK198805877A DK587788A DK173859B1 DK 173859 B1 DK173859 B1 DK 173859B1 DK 198805877 A DK198805877 A DK 198805877A DK 587788 A DK587788 A DK 587788A DK 173859 B1 DK173859 B1 DK 173859B1
- Authority
- DK
- Denmark
- Prior art keywords
- factor
- process according
- buffer
- fraction
- sodium chloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8714665A FR2622108B1 (fr) | 1987-10-23 | 1987-10-23 | Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique |
FR8714665 | 1987-10-23 | ||
FR8806923 | 1988-05-25 | ||
FR8806923A FR2631830B1 (fr) | 1988-05-25 | 1988-05-25 | Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique |
Publications (3)
Publication Number | Publication Date |
---|---|
DK587788D0 DK587788D0 (da) | 1988-10-21 |
DK587788A DK587788A (da) | 1989-04-24 |
DK173859B1 true DK173859B1 (da) | 2001-12-31 |
Family
ID=26226280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198805877A DK173859B1 (da) | 1987-10-23 | 1988-10-21 | Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner |
Country Status (8)
Country | Link |
---|---|
US (1) | US5457181A (es) |
EP (1) | EP0317376B2 (es) |
JP (1) | JP2768957B2 (es) |
DE (1) | DE3877529T2 (es) |
DK (1) | DK173859B1 (es) |
ES (1) | ES2045167T5 (es) |
GR (2) | GR3006910T3 (es) |
NO (1) | NO179997C (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3914869C1 (es) * | 1989-05-05 | 1990-08-09 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
IE73210B1 (en) * | 1990-01-24 | 1997-05-07 | Warner Lambert Co | Process for the production of thrombin and high purity thrombin preparation thereby obtained |
ATE177781T1 (de) * | 1990-02-20 | 1999-04-15 | Baxter Int | Gereinigtes, virusfreies menschliches thrombin |
AT402261B (de) * | 1991-01-25 | 1997-03-25 | Immuno Ag | Komplex enthaltend den gerinnungsfaktor ix |
DK0573605T3 (da) | 1991-03-01 | 2001-01-02 | Rhone Poulenc Rorer Int | Fremstilling af faktor IX |
FR2711371B1 (fr) * | 1993-10-18 | 1995-12-29 | Aetsrn | Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu. |
DE4342132C1 (de) * | 1993-12-10 | 1994-11-03 | Octapharma Ag | Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie |
DE4406515C1 (de) * | 1994-02-28 | 1995-10-19 | Immuno Ag | Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine |
US6372716B1 (en) | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
DE4435520A1 (de) * | 1994-10-04 | 1996-04-11 | Immuno Ag | Verfahren zur Trennung von rekombinantem pro-Faktor IX von rekombinantem Faktor IX |
DE19504852C2 (de) * | 1995-02-15 | 2003-01-23 | Octapharma Ag Lachen | Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Affinitäts-Chromatographie |
DE19506633A1 (de) * | 1995-02-25 | 1996-08-29 | Octapharma Ag | Verfahren zur Herstellung von Faktor IX aus biologischen Quellen |
US5714583A (en) * | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
ES2127695B1 (es) * | 1997-02-14 | 2000-03-16 | Grifols Grupo Sa | Procedimiento para la reduccion del contenido de factor plaquetar 4 en proteinas plasmaticas que poseen afinidad a heparina. |
AT407484B (de) * | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
CA2470511C (en) | 2001-12-21 | 2014-05-27 | Novo Nordisk Health Care Ag | Liquid composition of factor vii polypeptides |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
ES2523655T5 (es) * | 2002-06-21 | 2018-04-23 | Novo Nordisk Health Care Ag | Composiciones sólidas estabilizadas de polipéptidos del Factor VIIa |
SE0203551D0 (sv) * | 2002-12-02 | 2002-12-02 | Biovitrum Ab | Prothrombin purification |
US20040106779A1 (en) * | 2002-12-03 | 2004-06-03 | Bigler Douglas E. | Modified factor IX preparation |
AT501088A2 (de) * | 2002-12-18 | 2006-06-15 | Bio Prod & Bio Eng Ag | Stabile therapeutische proteine |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
WO2004103398A1 (en) * | 2003-05-23 | 2004-12-02 | Novo Nordisk Health Care Ag | Protein stabilization in solution |
WO2005002615A1 (en) * | 2003-07-01 | 2005-01-13 | Novo Nordisk Health Care Ag | Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
MXPA06001698A (es) | 2003-08-14 | 2006-05-19 | Novo Nordisk Healthcare Ag | Composicion farmaceutica liquida y acuosa de polipetidos de factor vii. |
WO2005033140A1 (ja) * | 2003-09-30 | 2005-04-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | 高純度血液凝固ix因子調製物およびその精製方法 |
EP3378470A1 (en) * | 2003-12-19 | 2018-09-26 | Novo Nordisk Health Care AG | Stabilised compositions of factor vii polypeptides |
DE602005024955D1 (de) | 2004-03-19 | 2011-01-05 | Baxter Healthcare Sa | Faktor ixa zur behandlung von blutungsstörungen |
KR100667860B1 (ko) | 2005-10-18 | 2007-01-11 | 주식회사 녹십자 | 고순도 사람 혈액응고 제9인자의 정제 방법 |
WO2008031020A2 (en) * | 2006-09-08 | 2008-03-13 | Wyeth | Arginine wash in protein purification using affinity chromatography |
WO2008104372A1 (en) * | 2007-02-28 | 2008-09-04 | Baxter International Inc. | Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules |
WO2008113589A1 (en) | 2007-03-20 | 2008-09-25 | Csl Behring Gmbh | Methods for industrial scale production of therapeutic complement factor h preparations from human plasma |
US20140051839A1 (en) * | 2010-11-16 | 2014-02-20 | Octapharma Ag | Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation Factors |
US9488625B2 (en) | 2010-12-15 | 2016-11-08 | Baxalta GmbH | Purification of factor VIII using a conductivity gradient |
US10378004B2 (en) | 2011-10-14 | 2019-08-13 | Baxalta GmbH | Protein purification by anion exchange chromatography |
US20140206844A1 (en) | 2013-01-18 | 2014-07-24 | Prothera Biologics | Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material |
US9663553B2 (en) | 2014-01-29 | 2017-05-30 | Hemarus Therapeutics Limited | Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma |
GB201506113D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
GB201506117D0 (en) * | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
CN110339209B (zh) * | 2019-07-18 | 2023-06-06 | 上海泰坦科技股份有限公司 | 一种去甲状腺结合蛋白的小牛血清的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2459291C3 (de) * | 1974-12-14 | 1981-06-04 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen |
US4374763A (en) * | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
DE3172210D1 (en) * | 1980-05-27 | 1985-10-17 | Miles Lab | Blood coagulation promoting product and process of preparing same |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
US4447416A (en) * | 1982-04-28 | 1984-05-08 | American National Red Cross | Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy |
US4397841A (en) * | 1982-06-28 | 1983-08-09 | Monsanto Company | Production of blood coagulation factor VIII:C |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
DE3336631A1 (de) * | 1983-10-08 | 1985-04-18 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x |
US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
DE3751605D1 (de) * | 1986-01-06 | 1996-01-04 | Blood Systems Inc | Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung. |
-
1988
- 1988-10-20 DE DE3877529T patent/DE3877529T2/de not_active Expired - Lifetime
- 1988-10-20 ES ES88402643T patent/ES2045167T5/es not_active Expired - Lifetime
- 1988-10-20 EP EP88402643A patent/EP0317376B2/fr not_active Expired - Lifetime
- 1988-10-21 DK DK198805877A patent/DK173859B1/da not_active IP Right Cessation
- 1988-10-21 NO NO884688A patent/NO179997C/no not_active IP Right Cessation
- 1988-10-22 JP JP63267004A patent/JP2768957B2/ja not_active Expired - Lifetime
-
1991
- 1991-04-11 US US07/683,109 patent/US5457181A/en not_active Expired - Lifetime
-
1993
- 1993-01-28 GR GR930400157T patent/GR3006910T3/el unknown
-
1996
- 1996-05-13 GR GR960401282T patent/GR3019900T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3019900T3 (en) | 1996-08-31 |
DE3877529T2 (de) | 1996-11-07 |
DK587788A (da) | 1989-04-24 |
JP2768957B2 (ja) | 1998-06-25 |
NO884688D0 (no) | 1988-10-21 |
DE3877529D1 (de) | 1993-02-25 |
EP0317376A1 (fr) | 1989-05-24 |
ES2045167T5 (es) | 1996-07-01 |
EP0317376B1 (fr) | 1993-01-13 |
EP0317376B2 (fr) | 1996-04-03 |
NO884688L (no) | 1989-04-24 |
NO179997C (no) | 1997-01-29 |
US5457181A (en) | 1995-10-10 |
NO179997B (no) | 1996-10-21 |
JPH01207239A (ja) | 1989-08-21 |
ES2045167T3 (es) | 1994-01-16 |
GR3006910T3 (en) | 1993-06-30 |
DK587788D0 (da) | 1988-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK173859B1 (da) | Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner | |
US5854403A (en) | Method for isolation of highly pure von Willebrand Factor | |
US4877866A (en) | Method of producing a virus safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation | |
US5344918A (en) | Process for the manufacture of a high-purity activated factor VII concentrate essentially free of vitamin K-dependent factors and factors VIIIC and VIIICAg | |
US4877608A (en) | Pharmaceutical plasma protein formulations in low ionic strength media | |
US4272523A (en) | Fractionating citrate-stabilized plasma | |
US4495175A (en) | Preparation of highly purified human antihemophilic factor | |
CA2024667C (en) | Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma | |
US4470969A (en) | Process for producing a concentrate of coagulation factors VII and VIIa | |
DK164282B (da) | Biologisk aktive fragmenter af human antihaemofilisk faktor viii:c, anvendelse af fragmenterne og fremgangsmaade til fremstilling af dem | |
US7648958B2 (en) | Factor VIII/vWF-complex and methods of purifying same | |
US4749783A (en) | Viral inactivation and purification of active proteins | |
US5252217A (en) | Blood coagulation factor XI concentrate having high specific activity, suitable for therapeutic use, and process for preparing same | |
JPH0580455B2 (es) | ||
JPH0424360B2 (es) | ||
US6063909A (en) | Preparation of factor IX | |
US4473553A (en) | Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa | |
KR100667860B1 (ko) | 고순도 사람 혈액응고 제9인자의 정제 방법 | |
Josic et al. | Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography | |
US4822872A (en) | Method of purifying factor VIII | |
JP3043558B2 (ja) | ヒト活性化プロテインc調製物及びその製法 | |
Wickerhauser et al. | A Single‐Step Method for the Isolation of Antithrombin III 1, 2 | |
EP0650364B1 (en) | Purification of factor ix | |
US20040106779A1 (en) | Modified factor IX preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |